top of page
์ด๋ฏธ์ง€ ์ œ๊ณต: Markus Spiske

Investor Relations

FINANCIAL INFORMATION

CONSOLIDATED BALANCE SHEET

(Unit: million won)

Category
2021
2022
2023
2024
Current Assets (Total)
67,519
75,655
81,929
97,148
Non-Current Assets
45,357
40,184
35,712
33,250
Total Assets
112,877
115,839
117,641
130,398
Current Liabilities
5,766
7,389
4,821
5,863
Non-Current Liabilities
423
358
934
367
Total Liabilities
6,189
7,747
5,755
6,229
Capital Stock
4,700
4,700
4,700
4,700
Capital Surplus
12,760
12,760
12,760
12,760
Retained Earnings
109,894
114,993
118,217
130,264
Total Equity
106,687
108,092
111,885
124,168

CONSOLIDATED INCOME STATEMENT

(Unit: million won)

Category
2021
2022
2023
2024
Sales Revenue
46,873
50,526
53,787
49,913
Gross Profit
35,683
37,951
38,975
36,060
Operating Income
7,257
6,051
2,195
6,796
Income Before Tax
12,090
10,172
6,880
15,610
Net Income
10,383
8,281
6,304
15,127

CONSOLIDATED CASH FLOW STATEMENT

(Unit: million won)

Category
2021
2022
2023
2024
Cash Flows from Operating Activities
14,892
12,814
7,815
19,267
Cash Flows from Investing Activities
-11,132
-6,669
-4,745
-18,737
Cash Flows from Financing Activities
-3,858
-7,538
-3,721
-3,741
Increase (Decrease) in Cash
260
-1,402
-574
-3,128
Beginning Cash Balance
9,600
9,860
8,458
7,884
Ending Cash Balance
9,860
8,458
7,884
4,757

DISCLOSURE

Date
Report Name
๋ณด๊ณ ์„œ๋ช…
Submitter
09/12/2025
Report on the Status of Ownership of Specific Securities by Executives and Major Shareholders
์ž„์›ใ†์ฃผ์š”์ฃผ์ฃผํŠน์ •์ฆ๊ถŒ๋“ฑ์†Œ์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ
์œค์˜์˜ฅ
28/11/2025
Report on the Status of Ownership of Specific Securities by Executives and Major Shareholders
์ž„์›ใ†์ฃผ์š”์ฃผ์ฃผํŠน์ •์ฆ๊ถŒ๋“ฑ์†Œ์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ
์œค์˜์˜ฅ
14/11/2025
Quarterly Report (2025.09)
๋ถ„๊ธฐ๋ณด๊ณ ์„œ (2025.09)
Cell Biotech
06/11/2025
Operating Results Based on Consolidated Financial Statements
์—ฐ๊ฒฐ์žฌ๋ฌด์ œํ‘œ๊ธฐ์ค€์˜์—…(์ž ์ •)์‹ค์ (๊ณต์ •๊ณต์‹œ)
Cell Biotech
14/08/2025
Semiannual Report (2025.06)
๋ฐ˜๊ธฐ๋ณด๊ณ ์„œ (2025.06)
Cell Biotech
07/08/2025
Operating Results Based on Consolidated Financial Statements
์—ฐ๊ฒฐ์žฌ๋ฌด์ œํ‘œ๊ธฐ์ค€์˜์—…(์ž ์ •)์‹ค์ (๊ณต์ •๊ณต์‹œ)
Cell Biotech
15/05/2025
Quarterly Report (2025.03)
๋ถ„๊ธฐ๋ณด๊ณ ์„œ (2025.03)
Cell Biotech
09/05/2025
Operating Results Based on Consolidated Financial Statements
์—ฐ๊ฒฐ์žฌ๋ฌด์ œํ‘œ๊ธฐ์ค€์˜์—…(์ž ์ •)์‹ค์ (๊ณต์ •๊ณต์‹œ)
Cell Biotech
30/04/2025
Change of Affiliated Division
์†Œ์†๋ถ€๋ณ€๊ฒฝ
KOSDAQ
02/04/2025
Report on the Status of Ownership of Specific Securities by Executives and Major Shareholders
์ž„์›ใ†์ฃผ์š”์ฃผ์ฃผํŠน์ •์ฆ๊ถŒ๋“ฑ์†Œ์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ
์ •ํ˜œ์ง€
02/04/2025
Report on the Status of Ownership of Specific Securities by Executives and Major Shareholders
์ž„์›ใ†์ฃผ์š”์ฃผ์ฃผํŠน์ •์ฆ๊ถŒ๋“ฑ์†Œ์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ
์ •์œ ์ˆ™
02/04/2025
Report on the Status of Ownership of Specific Securities by Executives and Major Shareholders
์ž„์›ใ†์ฃผ์š”์ฃผ์ฃผํŠน์ •์ฆ๊ถŒ๋“ฑ์†Œ์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ
์†ก์ˆ˜๊ทผ
27/03/2025
Outcomes of Annual Meeting of Shareholders
์ •๊ธฐ์ฃผ์ฃผ์ดํšŒ๊ฒฐ๊ณผ
Cell Biotech
19/03/2025
Submission of Audit Report
๊ฐ์‚ฌ๋ณด๊ณ ์„œ์ œ์ถœ
Cell Biotech
19/03/2025
Annual Report (2024.12)
์‚ฌ์—…๋ณด๊ณ ์„œ (2024.12)
Cell Biotech
13/03/2025
Reference Documents for Proxy Solicitation
์˜๊ฒฐ๊ถŒ๋Œ€๋ฆฌํ–‰์‚ฌ๊ถŒ์œ ์ฐธ๊ณ ์„œ๋ฅ˜
Cell Biotech
13/03/2025
Announcement of Convocation of General Meeting of Shareholders
์ฃผ์ฃผ์ดํšŒ์†Œ์ง‘๊ณต๊ณ 
Cell Biotech
27/02/2025
Resolution on Convening the General Meeting of Shareholders
์ฃผ์ฃผ์ดํšŒ์†Œ์ง‘๊ฒฐ์˜
Cell Biotech
27/02/2025
Report on the Reason for Holding the General Meeting of Shareholders on a Concentrated Date
์ฃผ์ฃผ์ดํšŒ์ง‘์ค‘์ผ๊ฐœ์ตœ์‚ฌ์œ ์‹ ๊ณ 
Cell Biotech
19/02/2025
Decision on Cash or In-kind Dividend
ํ˜„๊ธˆใ†ํ˜„๋ฌผ๋ฐฐ๋‹น๊ฒฐ์ •
Cell Biotech
19/02/2025
Change in Sales Revenue or Profit Structure by 30% (15% for Large Corporations) or More
๋งค์ถœ์•ก๋˜๋Š”์†์ต๊ตฌ์กฐ30%(๋Œ€๊ทœ๋ชจ๋ฒ•์ธ์€15%)์ด์ƒ๋ณ€๋™
Cell Biotech
12/02/2025
Report on the Status of Ownership of Specific Securities by Executives and Major Shareholders
์ž„์›ใ†์ฃผ์š”์ฃผ์ฃผํŠน์ •์ฆ๊ถŒ๋“ฑ์†Œ์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ
Lee Sang-hoon
06/02/2025
Report on the Status of Ownership of Specific Securities by Executives and Major Shareholders
์ž„์›ใ†์ฃผ์š”์ฃผ์ฃผํŠน์ •์ฆ๊ถŒ๋“ฑ์†Œ์œ ์ƒํ™ฉ๋ณด๊ณ ์„œ
Yoon Sung-bae
16/12/2024
Setting the Period for Closing the Shareholdersโ€™ Register or the Record Date
์ฃผ์ฃผ๋ช…๋ถ€ํ์‡„๊ธฐ๊ฐ„๋˜๋Š”๊ธฐ์ค€์ผ์„ค์ •
Cell Biotech
10/12/2024
Investor Relations (IR) Presentation
๊ธฐ์—…์„ค๋ช…ํšŒ(IR)๊ฐœ์ตœ
Cell Biotech
25/11/2024
Investor Relations (IR) Presentation
๊ธฐ์—…์„ค๋ช…ํšŒ(IR)๊ฐœ์ตœ
Cell Biotech
19/11/2024
Investor Relations (IR) Presentation
๊ธฐ์—…์„ค๋ช…ํšŒ(IR)๊ฐœ์ตœ
Cell Biotech
14/11/2024
Quarterly Report (2024.09)
๋ถ„๊ธฐ๋ณด๊ณ ์„œ (2024.09)
Cell Biotech
06/11/2024
Operating Results Based on Consolidated Financial Statements
์—ฐ๊ฒฐ์žฌ๋ฌด์ œํ‘œ๊ธฐ์ค€์˜์—…(์ž ์ •)์‹ค์ (๊ณต์ •๊ณต์‹œ)
Cell Biotech
02/09/2024
Corporate Presentation (IR)
๊ธฐ์—…์„ค๋ช…ํšŒ(IR)๊ฐœ์ตœ
Cell Biotech
16/08/2024
Corporate Presentation (IR)
๊ธฐ์—…์„ค๋ช…ํšŒ(IR)๊ฐœ์ตœ
Cell Biotech
14/08/2024
Semiannual Report (2024.06)
๋ฐ˜๊ธฐ๋ณด๊ณ ์„œ (2024.06)
Cell Biotech
07/08/2024
Corporate Presentation (IR)
๊ธฐ์—…์„ค๋ช…ํšŒ(IR)๊ฐœ์ตœ
Cell Biotech
06/08/2024
Operating Results Based on Consolidated Financial Statements
์—ฐ๊ฒฐ์žฌ๋ฌด์ œํ‘œ๊ธฐ์ค€์˜์—…(์ž ์ •)์‹ค์ (๊ณต์ •๊ณต์‹œ)
Cell Biotech
01/08/2024
Corporate Presentation (IR)
๊ธฐ์—…์„ค๋ช…ํšŒ(IR)๊ฐœ์ตœ
Cell Biotech
22/07/2024
Corporate Presentation (IR)
๊ธฐ์—…์„ค๋ช…ํšŒ(IR)๊ฐœ์ตœ
Cell Biotech
16/07/2024
Corporate Presentation (IR)
๊ธฐ์—…์„ค๋ช…ํšŒ(IR)๊ฐœ์ตœ
Cell Biotech
09/07/2024
Corporate Presentation (IR)
๊ธฐ์—…์„ค๋ช…ํšŒ(IR)๊ฐœ์ตœ
Cell Biotech
28/06/2024
Corporate Presentation (IR)
๊ธฐ์—…์„ค๋ช…ํšŒ(IR)๊ฐœ์ตœ
Cell Biotech
26/06/2024
Other Market Announcement (Notice of Industry Change)
๊ธฐํƒ€์‹œ์žฅ์•ˆ๋‚ด (์—…์ข…๋ณ€๊ฒฝ ์•ˆ๋‚ด)
KOSDAQ
16/05/2024
Quarterly Report (2024.03)
๋ถ„๊ธฐ๋ณด๊ณ ์„œ (2024.03)
Cell Biotech
08/05/2024
Operating Results Based on Consolidated Financial Statements
์—ฐ๊ฒฐ์žฌ๋ฌด์ œํ‘œ๊ธฐ์ค€์˜์—…(์ž ์ •)์‹ค์ (๊ณต์ •๊ณต์‹œ)
Cell Biotech
30/04/2024
Change of Affiliated Division
์†Œ์†๋ถ€๋ณ€๊ฒฝ
KOSDAQ

IR PRESENTATION

Copyright (c) 2024 Cell Biotech. All rights reserved.

HEADQUARTER

CELL BIOTECH  

Address

50, Aegibong-ro 409beon-gil, Gaegok-ri, Wolgot-myeon, Gimpo-si, Gyeonggi-do, Republic of Koreaโ€จ

Tel

(+82)31-987-6205 

SALES/MARKETING

CELL BIOTECH INTERNATIONAL

Address

3F, Bluecom Tower, Seocho-daero 274, Seocho-gu, Seoul, 06645, Korea

Tel

(+82)-2-2668-6077 

EUROPE OFFICE

CELL BIOTECH INTERNATIONAL A/S

Address

sorgenfrivej 15, 2800 Kongens Lyngby, Denmark

Tel

(+45) 3977-5040

bottom of page